DEUTSCHE BANK AG\ - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 25 filers reported holding PROTEON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$167,000
-6.2%
85,800
+17.9%
0.00%
Q2 2018$178,000
+249.0%
72,776
+1031.8%
0.00%
Q2 2016$51,000
+4.1%
6,430
-1.8%
0.00%
Q1 2016$49,000
+69.0%
6,547
+243.9%
0.00%
Q4 2015$29,0000.0%1,904
-10.4%
0.00%
Q3 2015$29,000
-12.1%
2,125
+14.7%
0.00%
Q2 2015$33,000
-62.9%
1,852
-78.4%
0.00%
Q4 2014$89,0008,5730.00%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Abingworth LLP 2,017,872$27,423,00016.02%
Monashee Investment Management LLC 77,102$1,072,0007.40%
Deer VII & Co. Ltd. 315,101$4,383,0004.15%
RA Capital Management 1,506,872$20,961,0003.01%
MPM ASSET MANAGEMENT LLC 983,381$13,679,0002.10%
Omega Fund Management, LLC 250,000$3,478,0001.96%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,343$17,601,0000.68%
Perceptive Advisors 550,000$7,650,0000.31%
TIVERTON ASSET MANAGEMENT LLC 375,000$5,216,0000.12%
Baker Brothers Advisors 274,617$3,820,0000.04%
View complete list of PROTEON THERAPEUTICS INC shareholders